- $INO Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure https://www.medrxiv.org/content/10.1101/2021.05.07.21256652v1 70 comments wallstreetbets